Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on FormS-8 of Intrexon Corporation of our report dated February 24, 2016, relating to the financial statements of ZIOPHARM Oncology, Inc. for the year ended December 31, 2015, appearing in Intrexon Corporation’s Annual Report on Form10-K for the year ended December 31, 2017.
/s/ RSM US LLP
Boston, Massachusetts
August 13, 2018